Note: Ingredients listed on restricted chemical lists
EC/CAS
200-663-8/67-66-3
Name of the chemical
Chloroform
Concentration
>=50-<70
EC/CAS
200-659-6/67-56-1
Name of the chemical
Methanol
Concentration
>=30-<50 603-001-
General Information
Version
6.18
Revision date
2025-03-13
Product name
Brain PI(4)P
1.2.2. Uses advised against
For R&D use only. Not for pharmaceutical, household or other uses
Emergency telephone
+1-703-527-3887
Icons in SDS
Company Information
company name
MilliporeSigma Canada Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
customerservice@avantiresearch.com, technical@avantiresearch.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H301+H331, H312, H315, H319, H336, H351, H361d, H370, H372
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Flammable liquids, (Category 2) H225: Highly flammable liquid and vapor. Acute toxicity, (Category 3) H301: Toxic if swallowed. Acute toxicity, (Category 3) H331: Toxic if inhaled. Acute toxicity, (Category 4) H312: Harmful in contact with skin. Skin irritation, (Category 2) H315: Causes skin irritation. Eye irritation, (Category 2) H319: Causes serious eye irritation. Carcinogenicity, (Category 2) H351: Suspected of causing cancer. Reproductive toxicity, (Category H361d: Suspected of damaging the unborn 2) child. Specific target organ toxicity - H370: Causes damage to organs. single exposure, (Category 1), Eyes, Central nervous system Specific target organ toxicity - H336: May cause drowsiness or dizziness. single exposure, (Category 3), Central nervous system Specific target organ toxicity - H372: Causes damage to organs through repeated exposure, (Category 1), prolonged or repeated exposure if Liver, Kidney swallowed.
Signal word
Danger Danger
Hazard statements
H225 Highly flammable liquid and vapor. H301 + H331 Toxic if swallowed or if inhaled. H312 Harmful in contact with skin. H315 Causes skin irritation. H319 Causes serious eye irritation. H336 May cause drowsiness or dizziness. H351 Suspected of causing cancer. H361d Suspected of damaging the unborn child. H370 Causes damage to organs (Eyes, Central nervous system). H372 Causes damage to organs (Liver, Kidney) through prolonged or repeated exposure if swallowed. H351 Suspected of causing cancer. H370 Causes damage to organs. H372 Causes damage to organs through prolonged or repeated exposure if swallowed. H361d Suspected of damaging the unborn child. H301 + H331 Toxic if swallowed or if inhaled.
Precautionary statements
P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P304 + P340 + P311 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. P304 + P340 + P311 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor.
Supplemental label elements
none For use in industrial installations only. Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.